# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-097509
Filing Date
2025-10-07
Accepted
2025-10-07 16:16:57
Documents
19
Period of Report
2025-11-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rzlt-20251119xdef14a.htm iXBRL | DEF 14A | 841213
2 | GRAPHIC | rzlt-20251119xdef14a_a011.jpg | GRAPHIC | 61409
3 | GRAPHIC | rzlt-20251119xdef14a_a012.jpg | GRAPHIC | 57427
4 | GRAPHIC | rzlt-20251119xdef14a_bg001.jpg | GRAPHIC | 133658
5 | GRAPHIC | rzlt-20251119xdef14a_bg002.jpg | GRAPHIC | 87221
| Complete submission text file | 0001104659-25-097509.txt |  | 2522466

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | rzlt-20251119.xsd | EX-101.SCH | 3203
7 | EX-101.LAB | rzlt-20251119_lab.xml | EX-101.LAB | 3685
8 | EX-101.PRE | rzlt-20251119_pre.xml | EX-101.PRE | 3939
21 | EXTRACTED XBRL INSTANCE DOCUMENT | rzlt-20251119xdef14a_htm.xml | XML | 273081

Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39683 | Film No.: 251380039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)